𝛼SK or Search

ENTITY

CanariaBio (016790 KS)

53

Analysis

Consumer Staples • South Korea

CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.

more

Refresh

Exchange Announcement • 01 Sep 2026 16:48

[Revised] Resolutions for Convocation of General Meeting of Shareholders(ììì£¼ì£¼ì´í)

Exchange Announcement • 06 Aug 2026 15:43

Filing or Application of Lawsuit, etc. (the Corporate Control Contest)

Exchange Announcement • 05 Aug 2026 17:11

Resolutions for Convocation of General Meeting of Shareholders(ììì£¼ì£¼ì´í)

Exchange Announcement • 02 Jul 2026 16:40

[Revised] Decision on Debt Guarantee for Others

Exchange Announcement • 30 Jun 2026 15:23

Change of CEO

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x